Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
157.21
-1.21 (-0.76%)
At close: May 18, 2026, 4:00 PM EDT
157.51
+0.30 (0.19%)
Pre-market: May 19, 2026, 6:52 AM EDT
Neurocrine Biosciences (NBIX) Revenue by Segment
History
| Date | Ingrezza | Collaboration and Other | Ongentys and Other Products |
|---|---|---|---|
| Mar 31, 2026 | 2.63B | 22.00M | 15.10M |
| Dec 31, 2025 | 2.51B | 26.60M | 19.10M |
| Sep 30, 2025 | 2.47B | 25.90M | 19.80M |
| Jun 30, 2025 | 2.40B | 26.40M | 18.30M |
| Mar 31, 2025 | 2.35B | 27.30M | 18.20M |
| Dec 31, 2024 | 2.31B | 24.70M | 17.20M |
| Sep 30, 2024 | 2.20B | 26.20M | 18.00M |
| Jun 30, 2024 | 2.07B | 27.70M | 20.40M |
| Mar 31, 2024 | 1.93B | 27.70M | 22.70M |
| Dec 31, 2023 | 1.84B | 26.50M | 24.60M |
| Sep 30, 2023 | 1.74B | 25.90M | 23.00M |
| Jun 30, 2023 | 1.63B | 27.50M | 19.80M |
| Mar 31, 2023 | 1.54B | 47.30M | 15.60M |
| Dec 31, 2022 | 1.43B | 47.80M | 13.10M |
| Sep 30, 2022 | 1.33B | 48.90M | 10.20M |
| Jun 30, 2022 | 1.24B | 47.50M | 9.60M |
| Mar 31, 2022 | 1.15B | 43.40M | 9.20M |
| Dec 31, 2021 | 1.08B | 43.40M | 8.20M |
| Sep 30, 2021 | 1.02B | 41.50M | 6.60M |
| Jun 30, 2021 | 988.80M | 38.70M | 4.40M |
Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.